Landscape Capital Management, L.L.C. Fulcrum Therapeutics, Inc. Transaction History
Landscape Capital Management, L.L.C.
- $1.1 Billion
- Q2 2024
A detailed history of Landscape Capital Management, L.L.C. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Landscape Capital Management, L.L.C. holds 10,489 shares of FULC stock, worth $39,543. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,489
Previous 94,775
88.93%
Holding current value
$39,543
Previous $894,000
92.73%
% of portfolio
0.01%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding FULC
# of Institutions
135Shares Held
59.5MCall Options Held
4.32MPut Options Held
307K-
Ra Capital Management, L.P. Boston, MA11.6MShares$43.8 Million1.08% of portfolio
-
Rtw Investments, LP New York, NY5.85MShares$22 Million0.61% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$18.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$11.6 Million0.0% of portfolio
-
Cowen And Company, LLC2.96MShares$11.2 Million0.47% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $196M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...